Evaluating the financial challenges of stem cell therapy is crucial for patients and policymakers alike. One significant factor influencing these costs is the Consumer Price Index (CPI). As clinical expenses continue to rise, tracked by the CPI, stem cell treatments are becoming more expensive. Understanding this relationship allows for prospective… Read More

When managed appropriately—as in, not considerably altered or augmented—autologous fat-derived stem cells are mainly exempt from oversight. The FDA also details out other basic safety concerns, like injection site reactions, the flexibility of stem cells injected into a person A part of the human body to migrate to a different portion, failure… Read More